[1] 王琳源，林晓萍，靳赢. RANKL介导的免疫应答在牙周病吸收中的作用[J].中华口腔医学杂志，2013，48（2）：115-118.[2] Chen HH，Huang N，Chen Y，et a1. Association between a history of periodontitis and the risk of rheumatoid arthritis:a nation wide,population-based,ease-control study[J].Ann Rheum Dis，2013，72(7)：1206-1211.[3] Wolff B，Berger T，Frese C，et al.Oral status in patients with early rheumatoid arthritis：a prospective，case-control study[J].Rheumatology(Oxford)，2014，53(3)：526-531.[4] Keller JJ，Kang JH，Lin HC.Association between anktysing spondulitis and chronic periodonttis:a population-based study[J].Arthritis Rheum，2013，65(1): 167-173. [5] Mercado F，Marshall RI，Klestov AC，et al.Is there a relationship between rheumatoid arthritis and periodontal disease? [J].J Clin Periodontol，2000，27(4)：267-272.[6] Ogrendik M. Effects of clarithromycin in patients with active rheumatoid arthritis[J].Curr Med Res Opin，2007，23(3)：515–522.[7] Erciyas K，Sezer U，Ustün K，et al.Effects of periodontal therapy on disease activity and systemic inflammation in rheumatoid arthritis patients[J].Oral Dis，2013，19(4)：394-400.[8] Queiroz-Junior CM，Bessoni RL，Costa VV，et al. Preventive and therapeutic anti-TNF-α therapy with pentoxifylline decreases arthritis and the associated periodontal co-morbidity in mice[J].Life Sci，2013，93(9-11)：423-428. [9] Loyola-Rodriguez JP，Martinez-Martinez RE，Abud-Mendoza C，et al.Rheumatoid arthritis and the role of oral bacteria[J].J Oral Microbiol，2010，2: 10.3402/jom.v2i0.5784.[10] Martinez-Martinez RE，Abud-Mendoza C，Pati?o-Marin N，et al. Detection of periodontal bacterial DNA in serum and synovial fluid in refractory rheumatoid arthritis patients[J].J Clin Periodontol，2009，36(12):1004–1010.[11] Lundberg K，Wegner N，Yucel-Lindberg T，et al.Periodontitis in RA-the citrullinated enolase connection[J].Nat Rev Rheumatol，2010，6(12）：727–730.[12] Kinloch AJ，Alzabin S，Brintnell W，et al.Immunization with Porphyromonas gingivalis enolase induces autoimmunity to mammalian α-enolase and arthritis in DR4-IE-transgenic mice[J].Arthritis Rheum，2011，63(12)：3818-3823.[13] Lange L，Thiele GM，Pichavant M，et al.A116：increased antibody responses to porphyromonas gingivalis in children with anticyclic citrullinated Peptide antibody-positive juvenile idiopathic arthritis[J].Arthritis Rheumatol，2014，66 Suppl 11：S153.[14] Mori G，Amelio P，Faccio R，et al.The Interplay between the Bone and the Immune System[J].Clin Dev Immunol，2013，2013：720504.[15] Kim J，Kang S，Kim J，et al.Elevated levels of T helper 17 cells are associated with disease activity in patients with rheumatoid arthritis[J].Ann Lab Med，2013，33(1)：52-59.[16] 陈淑增，白剑鹏，谢永华等.强直性脊柱炎患者外周血Th17、Treg、Th1免疫失衡及其与疾病活动相关性研究[J].中国免疫学杂志，2013，29(8)：834-838，847.[17] Okui T，Aoki Y，Ito H，et al.The presence of IL-17+/FOXP3+ double-positive cells in periodontitis[J].J Dent Res，2012，91(6)：574-579.[18] Zhao L，Zhou Y，Xu Y，et al.Effect of non-surgical periodontal therapy on the levels of Th17/Th1/Th2 cytokines and their transcription factors in Chinese chronic periodontitis patients[J].J Clin Periodontol，2011，38(6)：509-516.[19] Glowackia AJ，Yoshizawab S，Jhunjhunwala S，et al. Prevention of inflammation mediated bone loss in murine and canine periodontal disease via recruitment of regulatory lymphocytes[J].Proc Natl Acad Sci U S A，2013，110(46)：18525-18530.[20] Ertugrul AS，Sahin H，Dikilitas A，et al.Comparison of CCL28，interleukin-8，interleukin-1β and tumor necrosis factor-alpha in subjects with gingivitis，chronic periodontitis and generalized aggressive periodontitis[J].J Periodontal Res，2013，48(1)：44-51.[21] Ji Y，Yang X，Yang L，et al.Studies on correlation between single-nucleotide polymorphisms of tumor necrosis factor gene and different stages of ankylosing spondylitis[J].Cell Biochem Biophys，2013，67(3)：915-922. [22] Pers JO，Saraux A，Pierre R，et al.Anti-TNF-alpha immunotherapy is associated with increased gingival inflammation without clinical attachment loss in subjects with rheumatoid arthritis[J].J Periodontol，2008，79(9)：1645-1651.[23] Ortiz P，Bissada NF，Palomo L，et al.Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors[J].J Periodontol，2009，80(4)：535-540.[24] Chao TH，Yu HN，Huang CC，et al.Association of interleukin-1 beta（-511C/T）polymorphisms with osteoporosis in postmenopausal women[J].Ann Saudi Med，2010，30(6)：437-441.[25] 方絮，林晓萍.IL-23/IL-17炎性轴与牙周炎关系的研究进展[J].口腔医学，2014，34(5)：473-476.[26] 宋雪婧，詹渊博，张瑞敏.IL一17与牙周炎和类风湿性关节炎相关性的研究进展[J]. 国际免疫学杂志，2014，37（1）：44-48.[27] de Aquino SG，Abdollahi-Roodsaz S，Koenders MI，et al.Periodontal pathogens directly promote autoimmune experimental arthritis by inducing a TLR2- and IL-1-driven Th17 response[J].J Immunol，2014，1；192(9)：4103-4111.[28] Baeten D，Baraliakos X，Braun J，et al.Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis：a randomised, double-blind, placebo- controlled trial[J].Lancet，2013，382(9906)：1705-1713.[29] Tyagi AM，Mansoori MN，Srivastava K，et al.Enhanced Immunoprotective Effects by Anti-IL17 Antibody Translates to Improved Skeletal Parameters Under Estrogen Deficiency Compared to Anti-RANKL and Anti-TNFα Antibodies[J].J Bone Miner Res，2014. doi: 10.1002/jbmr.2228.[30] Zupan J，Jeras M，Marc J.Osteoimmunology and the infl uence of pro-inflammatory cytokines on osteoclasts[J]. Biochemia Medica，2013，23(1)：43–63.[31] Chen CH，Chen HA，Liao HT，et al.Soluble receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis：OPG is associated with poor physical mobility and reflects systemic inflammation[J].Clin Rheumatol，2010，29(10)：1155-1161.[32] 王琳源，林晓萍.RANKL在牙周炎骨吸收中的研究进展[J].口腔医学，2013，33(7)：493-495.[33] Taylan A，Sari I，Akinci B，et al.Biomarkers and cytokines of bone turnover：extensive evaluation in a cohort of patients with ankylosing spondylitis[J].BMC Musculoskelet Disord，2012，2；13：191.[34] Stolina M，Adamu S，Ominsky M，et al.RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis[J].J Bone Miner Res，2005， 20(10)：1756-1765. [35] Napimoga MN，Benatti BB，Lima FO，et al.Cannabidiol Decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats[J]. Int Immunopharmacol，2009，9(2)：216-222.[36] Baharuddin NA，Coates DE，Cullinan M，et al.Localization of RANK,RANKL and osteoprotegerin during healing of surgically created periodontal defects in sheep[J]. J Periodontal Res，2014. Doi：10.1111/jre.12196. [37] Han X，Lin X，Yu X，et al. Porphyromonas gingivalis infection associated periodontal bone resorption is receptor activator of nuclear factor-kappaB ligand (RANKL)-dependent[J]. Infect Immun，2013，81(5)：1502-1509..
